Literature DB >> 26910821

Mitochondrial Proteome Changes Correlating with β-Amyloid Accumulation.

Katalin Völgyi1,2, Krisztina Háden3, Viktor Kis4, Péter Gulyássy3,5, Kata Badics3, Balázs András Györffy3,6, Attila Simor3, Zoltán Szabó7, Tamás Janáky7, László Drahos5, Árpád Dobolyi8, Botond Penke7, Gábor Juhász3,5, Katalin Adrienna Kékesi3,9.   

Abstract

Alzheimer's disease (AD) is a multifactorial disease of wide clinical heterogenity. Overproduction of amyloid precursor protein (APP) and accumulation of β-amyloid (Aβ) and tau proteins are important hallmarks of AD. The identification of early pathomechanisms of AD is critically important for discovery of early diagnosis markers. Decreased brain metabolism is one of the earliest clinical symptoms of AD that indicate mitochondrial dysfunction in the brain. We performed the first comprehensive study integrating synaptic and non-synaptic mitochondrial proteome analysis (two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry) in correlation with Aβ progression in APP/PS1 mice (3, 6, and 9 months of age). We identified changes of 60 mitochondrial proteins that reflect the progressive effect of APP overproduction and Aβ accumulation on mitochondrial processes. Most of the significantly affected proteins play role in the mitochondrial electron transport chain, citric acid cycle, oxidative stress, or apoptosis. Altered expression levels of Htra2 and Ethe1, which showed parallel changes in different age groups, were confirmed also by Western blot. The common regulator bioinformatical analysis suggests the regulatory role of tumor necrosis factor (TNF) in Aβ-mediated mitochondrial protein changes. Our results are in accordance with the previous postmortem human brain proteomic studies in AD in the case of many proteins. Our results could open a new path of research aiming early mitochondrial molecular mechanisms of Aβ accumulation as a prodromal stage of human AD.

Entities:  

Keywords:  APP/PS1 mouse model; Alzheimer’s disease (AD); Non-synaptic mitochondria; Synaptic mitochondria; β-Amyloid (Aβ)

Mesh:

Substances:

Year:  2016        PMID: 26910821     DOI: 10.1007/s12035-015-9682-4

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  110 in total

1.  Transient structure of the amyloid precursor protein cytoplasmic tail indicates preordering of structure for binding to cytosolic factors.

Authors:  T A Ramelot; L N Gentile; L K Nicholson
Journal:  Biochemistry       Date:  2000-03-14       Impact factor: 3.162

2.  Memory impairment in transgenic Alzheimer mice requires cellular prion protein.

Authors:  David A Gimbel; Haakon B Nygaard; Erin E Coffey; Erik C Gunther; Juha Laurén; Zachary A Gimbel; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

3.  The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae.

Authors:  Camilla A Hansson Petersen; Nyosha Alikhani; Homira Behbahani; Birgitta Wiehager; Pavel F Pavlov; Irina Alafuzoff; Ville Leinonen; Akira Ito; Bengt Winblad; Elzbieta Glaser; Maria Ankarcrona
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

Review 4.  Brain aging, Alzheimer's disease, and mitochondria.

Authors:  Russell H Swerdlow
Journal:  Biochim Biophys Acta       Date:  2011-09-02

5.  The intracellular domain of the amyloid precursor protein (AICD) enhances the p53-mediated apoptosis.

Authors:  Toshinori Ozaki; Yuanyuan Li; Hironobu Kikuchi; Taisuke Tomita; Takeshi Iwatsubo; Akira Nakagawara
Journal:  Biochem Biophys Res Commun       Date:  2006-10-09       Impact factor: 3.575

6.  Mitochondrial ATP-synthase in the entorhinal cortex is a target of oxidative stress at stages I/II of Alzheimer's disease pathology.

Authors:  Beatrice Terni; Jordi Boada; Manuel Portero-Otin; Reinald Pamplona; Isidro Ferrer
Journal:  Brain Pathol       Date:  2009-02-27       Impact factor: 6.508

7.  Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy.

Authors:  Valeria Tiranti; Carlo Viscomi; Tatjana Hildebrandt; Ivano Di Meo; Rossana Mineri; Cecilia Tiveron; Michael D Levitt; Alessandro Prelle; Gigliola Fagiolari; Marco Rimoldi; Massimo Zeviani
Journal:  Nat Med       Date:  2009-01-11       Impact factor: 53.440

Review 8.  TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets.

Authors:  David Tweedie; Kumar Sambamurti; Nigel H Greig
Journal:  Curr Alzheimer Res       Date:  2007-09       Impact factor: 3.498

9.  Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.

Authors:  Tanea Reed; Marzia Perluigi; Rukhsana Sultana; William M Pierce; Jon B Klein; Delano M Turner; Raffaella Coccia; William R Markesbery; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2008-01-05       Impact factor: 5.996

10.  Soluble α-synuclein is a novel modulator of Alzheimer's disease pathophysiology.

Authors:  Megan E Larson; Mathew A Sherman; Susan Greimel; Michael Kuskowski; Julie A Schneider; David A Bennett; Sylvain E Lesné
Journal:  J Neurosci       Date:  2012-07-25       Impact factor: 6.167

View more
  6 in total

1.  Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.

Authors:  Katalin Völgyi; Kata Badics; Fernando J Sialana; Péter Gulyássy; Edina Brigitta Udvari; Viktor Kis; László Drahos; Gert Lubec; Katalin Adrienna Kékesi; Gábor Juhász
Journal:  Mol Neurobiol       Date:  2018-02-22       Impact factor: 5.590

Review 2.  Energy matters: presynaptic metabolism and the maintenance of synaptic transmission.

Authors:  Sunan Li; Zu-Hang Sheng
Journal:  Nat Rev Neurosci       Date:  2021-11-15       Impact factor: 34.870

Review 3.  When nature's robots go rogue: exploring protein homeostasis dysfunction and the implications for understanding human aging disease pathologies.

Authors:  Julie A Reisz; Alexander S Barrett; Travis Nemkov; Kirk C Hansen; Angelo D'Alessandro
Journal:  Expert Rev Proteomics       Date:  2018-03-21       Impact factor: 3.940

4.  Highly potent intracellular membrane-associated Aβ seeds.

Authors:  Anne-Marie Marzesco; Matthias Flötenmeyer; Anika Bühler; Ulrike Obermüller; Matthias Staufenbiel; Mathias Jucker; Frank Baumann
Journal:  Sci Rep       Date:  2016-06-17       Impact factor: 4.379

Review 5.  Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases.

Authors:  Hibiki Kawamata; Giovanni Manfredi
Journal:  J Cell Biol       Date:  2017-11-22       Impact factor: 10.539

6.  Physical exercise may exert its therapeutic influence on Alzheimer's disease through the reversal of mitochondrial dysfunction via SIRT1-FOXO1/3-PINK1-Parkin-mediated mitophagy.

Authors:  Na Zhao; Jie Xia; Bo Xu
Journal:  J Sport Health Sci       Date:  2020-08-28       Impact factor: 7.179

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.